How do the long-term benefits and complicating factors of bariatric surgery in type 1 diabetes patients compare to those with type 2?
Read More »Calorie Restriction vs. Bariatric Surgery for T2D Remission
A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.
Read More »Socioeconomic Status and Obesity in Patients with Diabetes
Are socioeconomic factors and obesity independently related to diabetes prevalence?
Read More »Waist Circumference and Early Detection of Diabetes
Measuring waist circumference could provide an inexpensive way to assess risk of developing insulin resistance.
Read More »Weight Loss Surgery and The Long-Term Impacts for Patients with Diabetes
Weight loss surgery may change the way the brain responds to food cues.
Read More »Small Weight Loss Provides Positive Glucose Control for T2D
A loss of as little as 2-3% of a patient’s total body weight can help them achieve better blood glucose levels.
Read More »Semaglutide 2.4 mg Once Weekly for Weight Management in Patients With Or Without T2D
Patients who have obesity but don't have diabetes may now reap the benefits of using a GLP-1 receptor agonist.
Read More »Don’t Blame All Symptoms on Glucose Levels
A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.
Read More »Greater Weight Loss Found With SGLT-2 Inhibitors Than GLP-1 RAs in Patients with T2D
Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin.
Read More »ADA 2021: Are Patients with Obesity or Diabetes at Increased Risk for Severe COVID-19?
Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.